Senators are continuing to push for new regulations around the Pharmacy Benefit Manager (PBM) industry.
Senators are continuing to push for new regulations around the Pharmacy Benefit Manager (PBM) industry. With the reintroduction of the Pharmacy Benefit Manager Transparency Act, which aims to increase drug pricing transparency and suppress PBM practices, such as spread pricing and payment claw backs, it would ultimately require the FTC to study consolidation in the PBM industry. Dr. Darwin Hale, CEO of Advocate Health Advisors shares his thoughts, stating “PBM regulations are going to be a top priority for lawmakers and for federal agencies in general. Both parties obviously have strong opinions and objectives, but they agree on drug pricing and oversite. There's renewed focus on PBMs because they are an intermediary and because price transparency isn't quite where Congress would like it.” Read the full article for Dr. Hale’s insights. #PBM #medicareadvantage #prescriptions #healthcare
Dr. Darwin Hale, Advocate Health Advisors CEO & Founder Joins Forbes Business Council
Advocate Health Advisors is proud to announce Dr. Darwin Hale, CEO and Founder has joined the Forbes Business Council!